Susquehanna International Group, LLP Xtl Biopharmaceuticals LTD Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.43 - $2.98 $59,761 - $124,537	-41,791 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.7 - $2.21 $1,890 - $2,457	1,112 Added 2.73%	41,791 $85,000
Q2 2018 Aug 14, 2018	BUY	$1.55 - $2.41 $45,148 - $70,198	29,128 Added 252.17%	40,679 $75,000
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.84 $27,722 - $32,804	11,551	11,551 $27,000

452K

Ticker XTLB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,449,060
Market Cap $13.9M
Description
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Ye...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.